Investigational COVID-19 Convalescent Plasma

The FDA released updated guidance on April 8, 2020, to care providers and investigators regarding administration and study of convalescent plasma and guidance to blood establishments on the collection of COVID-19 convalescent plasma. Learn more by accessing this document.

Please Register or Login

You must be logged in to access exclusive content within our clinical resources.

Register Log-in